Results 81 to 90 of about 61,140 (175)

Glucose Metabolic Rate Kinetic Model Parameter Determination in Humans: The Lumped Constants and Rate Constants for [¹⁸F]Fluorodeoxyglucose and [¹¹C]Deoxyglucose

, 1985
Martin Reivich, Abass Alavi, Alfred P. Wolf, Joanna S. Fowler, Jerome A. G. Russell, Carroll D. Arnett, Robert MacGregor, Chyng‐Yann Shiue, Harold Atkins, Vijaya Anand Arumugam, Robert Dann, Joel Greenberg   +11 more
openalex   +1 more source

3D Lymphoma Segmentation on PET/CT Images via Multi-Scale Information Fusion with Cross-Attention [PDF]

arXiv
Background: Accurate segmentation of diffuse large B-cell lymphoma (DLBCL) lesions is challenging due to their complex patterns in medical imaging. Objective: This study aims to develop a precise segmentation method for DLBCL using 18F-Fluorodeoxyglucose (FDG) positron emission tomography (PET) and computed tomography (CT) images.
arxiv  

Effects of Percent Thresholding on the Extraction of [¹⁸F]Fluorodeoxyglucose Positron Emission Tomographic Region-of-Interest Data

, 1991
David A. Rottenberg, James R. Moeller, Stephen C. Strother, Vijay Dhawan, M. L. Sergi   +4 more
openalex   +1 more source

No relationship between 18F-fluorodeoxyglucose positron emission tomography and expression of Glut-1 and -3 and hexokinase I and II in high-grade glioma

, 1994
Charnley
openalex   +2 more sources

Can positron emission tomography with [¹⁸F]‐fluorodeoxyglucose after first‐line treatment distinguish Hodgkin's disease patients who need additional therapy from others in whom additional therapy would mean avoidable toxicity? [PDF]

, 2001
Karoline Spaepen, Sigrid Stroobants, Patrick Dupont, José Thomas, Peter Vandenberghe, Jan Balzarini, Christine De Wolf‐Peeters, Luc Mortelmans, Gregor Verhoef   +8 more
openalex   +1 more source

Editorial: Targeting glucose metabolism in cancer immunity and immunotherapy

Frontiers in Immunology, 2023
Olivier Feron, Olivier Feron, Chih-Hao Chang, Frédérique Végran, Frédérique Végran, Frédérique Végran, Frédérique Végran   +6 more
doaj   +1 more source

Functional Imaging Constrained Diffusion for Brain PET Synthesis from Structural MRI [PDF]

arXiv
Magnetic resonance imaging (MRI) and positron emission tomography (PET) are increasingly used in multimodal analysis of neurodegenerative disorders. While MRI is broadly utilized in clinical settings, PET is less accessible. Many studies have attempted to use deep generative models to synthesize PET from MRI scans.
arxiv  

AutoPET III Challenge: Tumor Lesion Segmentation using ResEnc-Model Ensemble [PDF]

arXiv
Positron Emission Tomography (PET) /Computed Tomography (CT) is crucial for diagnosing, managing, and planning treatment for various cancers. Developing reliable deep learning models for the segmentation of tumor lesions in PET/CT scans in a multi-tracer multicenter environment, is a critical area of research.
arxiv  

Early restaging positron emission tomography with 18F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin’s lymphoma [PDF]

, 2002
Karoline Spaepen, Sigrid Stroobants, Patrick Dupont, Peter Vandenberghe, José Thomas, Tjibbe de Groot, Jan Balzarini, C. De Wolf‐Peeters, L. Mortelmans, G. Verhoef   +9 more
openalex   +1 more source

Neuroradiological features of traumatic encephalopathy syndrome using MRI and FDG-PET imaging: a case series in Australia [PDF]

arXiv
Objectives: This study examined whether currently existing clinical structural magnetic resonance imaging (MRI) and fluorodeoxyglucose positron emission tomography (18FDG-PET) capabilities and board-certified radiologists' reports and interpretations can assist with traumatic encephalopathy syndrome (TES) diagnosis.
arxiv